• Molecular NameMethylprednisolone
  • Synonym6alpha-Methylprednisolone; Methyleneprednisolone; Methylprednisolon; Methylprednisolonum [INN-Latin]; Metilprednisolona [INN-Spanish]; Metilprednisolone [Dcit]
  • Weight374.477
  • Drugbank_IDDB00959
  • ACS_NO83-43-2
  • Show 3D model
  • LogP (experiment)2.134
  • LogP (predicted, AB/LogP v2.0)1.97
  • pkaN/A
  • LogD (pH=7, predicted)1.97
  • Solubility (experiment)0.12 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.75
  • LogSw (predicted, AB/LogsW2.0)0.14
  • Sw (mg/ml) (predicted, ACD/Labs)0.07
  • No.of HBond Donors3
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds2
  • TPSA94.83
  • StatusFDA approved
  • AdministrationIV, IM, IV Infusion, oral
  • PharmacologyA synthetic glucocorticoid drug.
  • Absorption_value82.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability82.0
  • Protein binding78.0
  • Volume of distribution (VD)1.2 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • Metabollsmliver primarily, kidney, tissues; CYP450: 3A4 substrate
  • Half life2.3 h
  • ExcretionN/A
  • Urinary Excretion4.9
  • Clerance6.2 ml/min/kg
  • ToxicityN/A
  • LD50 (rat)LD50=2000 mg/kg
  • LD50 (mouse)N/A